Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5880378 | 1.00 | WNT3A (0.34) | WNT3ATNKS2 | |
| Phosphoric Acid SCHEMBL6630320 | 0.99 | WNT3A (0.34) | WNT3ATNKS2 | |
| SCHEMBL5880375 | 0.93 | WNT3A (0.34) | WNT3ATNKS2 | |
| Hydrochloric Acid SCHEMBL5880349 | 0.92 | WNT3A (0.34) | WNT3ATNKS2 | |
| SCHEMBL7299546 | 0.75 | WNT3A (0.34) | WNT3ATNKS2 | |
| Hydrochloric Acid SCHEMBL7304498 | 0.59 | — | — | |
| SCHEMBL7299920 | 0.59 | TNKS (0.34) | WNT3ATNKS2 | |
| SCHEMBL15663037 | 0.58 | GUCY1B2 (0.34) | — | |
| SCHEMBL7296866 | 0.57 | — | — | |
| SCHEMBL7304154 | 0.56 | BACE1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391796-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | SIMON FRASER UNIVERSITY (CA) | 2023-12-07 | — | — | US | disclosed |
| CN-116916916-A | Glycosidase inhibitors and uses thereof | 塞维利亚大学 | 2023-10-20 | — | — | CN | disclosed |
| EP-4217360-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | Universidad de Sevilla (US) - University of Seville (US) (ES) | 2023-08-02 | — | — | EP | disclosed |
| CN-110797514-B | Molybdenum-nitrogen co-doped flower-shaped carbon nanosphere/sulfur composite material, preparation method thereof and application of composite material in positive electrode of lithium-sulfur battery | 温州大学 | 2022-08-30 | — | — | CN | disclosed |
| WO-2022064429-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | VOCADLO DAVID (CA) | 2022-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391796-A1 | GLYCOSIDASE INHIBITORS AND USES THEREOF | OGA, OGT, ENGASE | WNT3A 3102/4885TNKS2 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.